Trial tests personalized vs. standard dosing to tame tough diabetes
NCT ID NCT07472725
Summary
This study is testing a new drug called SHR-3167 for adults whose type 2 diabetes isn't well-managed with current pills. It will compare two methods for adjusting the drug dose: a standard fixed plan and a plan tailored to each person. The main goal is to see which method is safer and better at controlling blood sugar, with a special focus on avoiding dangerously low blood sugar levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210003, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Peking University Shenzhen Hospital
Shenzhen, Guangdong, 518000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.